Metro-Minnesota Community Clinical Oncology Program

明尼苏达都会区社区临床肿瘤学计划

• 批准号: 8850956
• 负责人: Joseph Leach
• 金额: $ 40.16万
• 依托单位: PARK NICOLLET INSTITUTE
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-01 至 2014-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8850956
• 关键词: Adjuvant; American Cancer Society; Area; Award; Awareness; Back; Cancer Center; Cancer Control; Cancer Information Service; Cancer Patient; Cancer Trials Support Unit; Chemoprevention; Clinical; Clinical Oncology; Clinical Research; Clinical Trials; Clinics and Hospitals; Communication; Communities; Community Clinical Oncology Program; Community Hospitals; Community Physician; Comprehensive Cancer Center of Wake Forest University; Controlled Clinical Trials; Data; Data Collection; Doctor of Medicine; Eastern Cooperative Oncology Group; Enrollment; Environment; Evaluation; Family Practice; Funding; Future; Goals; Grant; Growth; Gynecologic Oncology; Gynecologic Oncology Group; Health; Health Care Reform; Health Planning; Health Planning Councils; Health Professional; Hematology; Hospital Administration; Hospitals; Improve Access; Institutes; Institution; Institutional Review Boards; Internal Medicine; Intestinal Cancer; Knowledge; Link; Malignant Neoplasms; Marketing; Medical Oncology; Minnesota; Minority; Modeling; National Cancer Institute; National Surgical Adjuvant Breast and Bowel Project; Neurology; North Central Cancer Treatment Group; Nursing Societies; Oncologic Nursing; Oncologist; Oncology Group; Oncology Nurse; Operations Research; Operative Surgical Procedures; Pamphlets; Participant; Patient Recruitments; Patients; Physicians; Prevention Protocols; Primary Care Physician; Principal Investigator; Protocols documentation; Quality of life; Radiation Oncology; Radiation Therapy Oncology Group; Recording of previous events; Reporting; Research; Research Design; Research Personnel; Resources; Specialist; Surgical Oncology; Surgical Specialties; System; Thoracic Surgical Procedures; Time; Toxic effect; Underrepresented Minority; Universities; Urology; base; cancer care; cancer prevention; cancer therapy; data management; follow-up; improved; malignant breast neoplasm; meetings; member; oncology; oncology program; organizational structure; programs; protocol development; research and development; research study; success; symptom management; web site

DESCRIPTION (provided by applicant): The Metro-Minnesota Community Clinical Oncology (MMCCOP) program has a long-standing history which clearly demonstrates the success of the consortium as demonstrated by the both the ongoing commitment of the original consortium members and the growth of the consortium from 1979 through 2009. The MMCCOP consortium represents an established community program base which began in 1979 through its NCI-funded Community Hospital Cancer Program (CHCP) Award. This program would have a major impact on the way that cancer care is delivered in the community and provided the cornerstone for this CCOP initiative. This same consortium applied for and received the initial Community Clinical Oncology Program (CCOP) grant from the NCI in 1983, and has received subsequent CCOP grants since that time in 1987, 1990, 1995, and 2000 and 2005. Currently, the MMCCOP consortium represents twelve hospital and clinics with a common approach and established mechanisms for identifying, enrolling and following participants on NCI sponsored treatment, cancer prevention and cancer control protocols. The health market In the MMCCOP community remains extremely competitive and is in constant change as a result of mergers and Minnesota's healthcare reform. Despite this changing environment, the MMCCOP hospitals and associated staff continue to collaborate and support the added time and expense Involved In clinical research trials. Their level of support has not been cut back, and In fact has increased, during a time when many other projects within the hospitals are being reduced or eliminated. This program incorporates a substantial segment of the practicing physician community, and has provided a basis for communications between the practicing oncologists, their hospital administrations, and other health professionals in this consortium for the past twenty-five years. Combined, the consortium members see an average of nearly 12,000 new analytic cancer patients per year. Currently, there are 110 Investigators, representing medical, radiation and surgical oncology Including neuro-surgery, thoracic surgery and gynecologic oncology, and hematology, urology, oncology, neurology, ENT, family practice and Internal medicine. The history of MMCCOP Research Base Affiliations and proactive approach to expanding access to NCI sponsored studies supports the ability to achieve and maintain the NCI goals for the CCOP Initiative. MMCCOP intends to sustain a region wide community consortium which provides the community with the most recent advances in cancer prevention, treatment and symptom management. This will be accomplished through continued affiliations with CTSU, ECOG, NCCTG, GOG, MD Anderson, NSABP, RTOG, URCC and CCCWFU, the expansion of the current MMCCOP data management and communication system to increase the number and level of participation of the investigators In accrual, program operations and research base activities, implementation of new strategies to improve access and participation of minority and underserved groups, and increase the professional and lay community awareness of the CCOP and benefits of clinical cancer trials. In addition, all member and affiliate institutions of both Metro-MN CCOP and MN CGOP research programs are members of the Institutional Review Board for the Community Oncology Programs, administered by Park Nicollet Institute. The application is submitted as MMCCOP completes Grant Year 26 with one of most successful years since initiation of this consortium program. During the most recent NCI-Funded grant (6/05-5/09), 242 credits (235 patients) were accrued to NCI- approved treatment studies and 372.8 credits (396 new patients and follow-up of 370 participants) were accrued to approved cancer control protocols. MMCCCOP has demonstrated the ability to enter an increasing number of patients on protocol each year and proposes to accrue a total of 240 credits to Treatment studies and 350 Cancer Control credits in the first year of this award with the goal of continually exceeding the NCI requirements for both types of studies.

描述（由申请人提供）：明尼苏达都会区社区临床肿瘤学 (MMCCOP) 计划有着悠久的历史，这清楚地表明了该联盟的成功，原联盟成员的持续承诺和联盟成员的发展就证明了这一点。从 1979 年到 2009 年一直是一个联盟。MMCCOP 联盟代表了一个已建立的社区计划基础，该基础于 1979 年通过其 NCI 资助的社区医院癌症计划 (CHCP) 奖开始。该计划将对社区癌症护理的提供方式产生重大影响，并为 CCOP 举措奠定了基石。该联盟于 1983 年向 NCI 申请并获得了最初的社区临床肿瘤学计划 (CCOP) 拨款，此后又于 1987 年、1990 年、1995 年、2000 年和 2005 年获得了后续 CCOP 拨款。目前，MMCCOP 联盟代表十二家医院和诊所采用共同方法和既定机制来识别、招募和跟踪 NCI 资助的治疗、癌症预防和治疗的参与者癌症控制协议。 MMCCOP 社区的医疗市场仍然极具竞争力，并且由于合并和明尼苏达州的医疗改革而不断变化。尽管环境不断变化，MMCCOP 医院和相关工作人员仍继续合作并支持临床研究试验所涉及的额外时间和费用。在医院内许多其他项目被减少或取消的时候，他们的支持水平并没有减少，事实上还增加了。该计划涵盖了执业医师界的很大一部分，并在过去二十五年里为该联盟的执业肿瘤学家、医院管理人员和其他卫生专业人员之间的沟通提供了基础。该联盟成员每年平均接待近 12,000 名新的分析癌症患者。目前，共有 110 名研究人员，分别代表医学、放射和外科肿瘤学，包括神经外科、胸外科和妇科肿瘤学，以及血液学、泌尿学、肿瘤学、神经学、耳鼻喉科、家庭医学和内科。 MMCCOP 研究基地附属机构的历史以及扩大 NCI 赞助研究的积极主动方法支持实现和维持 CCOP 计划的 NCI 目标的能力。 MMCCOP 旨在维持一个区域范围的社区联盟，为社区提供癌症预防、治疗和症状管理方面的最新进展。这将通过继续与 CTSU、ECOG、NCCTG、GOG、MD Anderson、NSABP、RTOG、URCC 和 CCCWFU 保持联系、扩展当前 MMCCOP 数据管理和通信系统以增加调查人员参与的数量和水平来实现。权责发生制、计划运营和研究基础活动，实施新战略以改善少数群体和服务不足群体的获取和参与，并提高专业人士和非专业社区对 CCOP 和临床癌症试验益处的认识。此外，Metro-MN CCOP 和 MN CGOP 研究计划的所有成员和附属机构都是由 Park Nicollet 研究所管理的社区肿瘤学计划机构审查委员会的成员。该申请是在 MMCCOP 完成资助第 26 年时提交的，这是自该联盟计划启动以来最成功的年份之一。在最近一次 NCI 资助的资助期间（6/05-5/09），NCI 批准的治疗研究累积了 242 个学分（235 名患者），并为 NCI 批准的治疗研究累积了 372.8 个学分（396 名新患者和 370 名参与者的随访）。批准的癌症控制方案。 MMCCCOP 已证明有能力每年让越来越多的患者参加方案，并建议在该奖项的第一年累计 240 个治疗研究学分和 350 个癌症控制学分，目标是不断超过 NCI 的要求两种类型的研究。